Omnicell, Inc. (NASDAQ:OMCL) Shares Purchased by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC increased its position in shares of Omnicell, Inc. (NASDAQ:OMCL) by 197.9% during the first quarter, Holdings Channel reports. The fund owned 124,600 shares of the company’s stock after acquiring an additional 82,774 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Omnicell were worth $3,642,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Benjamin Edwards Inc. boosted its position in Omnicell by 36.4% during the first quarter. Benjamin Edwards Inc. now owns 3,253 shares of the company’s stock worth $95,000 after acquiring an additional 868 shares during the last quarter. Strs Ohio boosted its position in Omnicell by 28.2% during the fourth quarter. Strs Ohio now owns 5,000 shares of the company’s stock worth $188,000 after acquiring an additional 1,100 shares during the last quarter. Diversified Trust Co boosted its position in Omnicell by 10.2% during the fourth quarter. Diversified Trust Co now owns 12,544 shares of the company’s stock worth $472,000 after acquiring an additional 1,162 shares during the last quarter. M&T Bank Corp boosted its holdings in shares of Omnicell by 16.0% in the 4th quarter. M&T Bank Corp now owns 9,570 shares of the company’s stock valued at $360,000 after purchasing an additional 1,321 shares during the last quarter. Finally, Arkadios Wealth Advisors boosted its holdings in shares of Omnicell by 6.2% in the 4th quarter. Arkadios Wealth Advisors now owns 22,985 shares of the company’s stock valued at $865,000 after purchasing an additional 1,341 shares during the last quarter. Institutional investors and hedge funds own 97.70% of the company’s stock.

Omnicell Stock Performance

NASDAQ:OMCL opened at $26.77 on Friday. The company has a current ratio of 2.38, a quick ratio of 2.13 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $1.23 billion, a price-to-earnings ratio of -58.20, a PEG ratio of 90.82 and a beta of 0.80. The firm’s fifty day simple moving average is $29.25 and its 200 day simple moving average is $29.84. Omnicell, Inc. has a twelve month low of $25.12 and a twelve month high of $75.07.

Omnicell (NASDAQ:OMCL) last posted its earnings results on Thursday, May 2nd. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.17. The business had revenue of $246.15 million for the quarter, compared to analyst estimates of $235.70 million. Omnicell had a negative net margin of 1.91% and a positive return on equity of 2.41%. As a group, equities research analysts expect that Omnicell, Inc. will post 0.2 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

OMCL has been the topic of a number of research analyst reports. StockNews.com upgraded shares of Omnicell from a “hold” rating to a “buy” rating in a report on Monday. Benchmark reiterated a “buy” rating and issued a $38.00 price target on shares of Omnicell in a report on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, Omnicell currently has an average rating of “Hold” and a consensus price target of $42.20.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.